{"filings":[{"id":118314,"accession_number":"0001477932-25-009277","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2025-12-31T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Shareholders approve exercise of warrants for 2.79M shares of Creative Medical Technology","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Warrants to purchase 2,790,340 shares issued Oct 29, 2025, approved at Dec 26 special meeting.","Vote: 618,178 For, 183,985 Against, 235,381 Abstain (220,500 For votes reclassified as Abstain per Nasdaq rules).","Quorum of 36.4% of outstanding shares was present at the special meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118313,"accession_number":"0001477932-25-009094","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2025-12-19T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"All five director nominees elected at 2025 annual meeting; say-on-pay and auditor ratified","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Five director nominees elected: For votes 419,951–434,837; withhold votes under 57,000 each.","Say-on-pay compensation approved: 335,623 For, 108,092 Against, 32,561 Abstain, 1,113,524 broker non-votes.","Ratification of Haynie & Company as auditor approved: 1,346,871 For, 115,979 Against, 126,950 Abstain.","Quorum of 1,589,800 shares (61.5% of outstanding) present at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118312,"accession_number":"0001477932-25-008027","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Creative Medical Technology Holdings approves $100k CEO and $25k CFO bonuses","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Compensation Committee approved bonuses on November 6, 2025","CEO Timothy Warbington receives $100,000 bonus","CFO Donald Dickerson receives $25,000 bonus","Bonuses disclosed in Item 5.02 of Form 8-K filed November 12, 2025"],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118311,"accession_number":"0001477932-25-007849","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2025-10-31T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"CELZ raises ~$4.2M via warrant exercise inducement; issues 2.79M new warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Holders of 1,116,136 warrants exercised at $3.75/share, yielding $4.2M gross proceeds.","Company issued 2,790,340 new inducement warrants at $3.75/share, exercisable 5 years after shareholder approval.","Roth Capital received 8% fee plus $40,000 expense reimbursement for acting as financial advisor.","Proceeds to be used for working capital and general corporate purposes.","Exercise price of certain 2021/2022 warrants reduced to $4.73 per share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151666,"accession_number":"0001477932-25-003370","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Stockholders approve exercise of warrants for 1.8M shares at special meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting on May 5, 2025; 35% quorum (813,562 shares) present.","Proposal to exercise warrants on 1,799,774 shares approved: 308,051 For, 39,229 Against, 466,282 Abstain.","Warrants were issued March 6, 2025; approval allows immediate exercise.","No broker non-votes reported; warrants represent ~78% of outstanding shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.15,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151665,"accession_number":"0001477932-25-002645","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2025-04-11T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"Creative Medical receives Nasdaq notice for late clawback policy adoption; matter closed as now compliant.","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["On April 8, 2025, Nasdaq notified Creative Medical for failure to timely adopt and disclose Clawback Policy per Listing Rule 5608.","Company adopted policy on April 4, 2025 with retroactive effect to Dec 1, 2023; no incentive compensation affected.","Nasdaq confirmed company currently in compliance and matter is closed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170515,"accession_number":"0001477932-25-001737","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2025-03-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Creative Medical Tech awards $100k in bonuses to CEO and CFO","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Timothy Warbington received a $70,000 bonus approved March 10, 2025.","CFO Donald Dickerson received a $30,000 bonus on the same date.","Bonuses were approved by the Compensation Committee of the Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170514,"accession_number":"0001477932-25-001537","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2025-03-07T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Creative Medical Technology raises $3.7M via warrant exercise inducement; issues new warrants at $3.75","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$3.7M from cash exercise of 837,104 existing warrants at $4.42/share.","Issued new inducement warrants to purchase 1,674,208 shares at $3.75, 5-year term, exercisable after stockholder approval.","New warrants unregistered; company to file resale registration on Form S-3 within 30 days.","Roth Capital receives 8% fee plus warrants for 5% of shares underlying exercised and new warrants.","Proceeds will be used for working capital and general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187508,"accession_number":"0001477932-24-008314","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2024-12-26T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Shareholders vote to increase authorized shares from 5M to 25M, approve warrant exercise","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized common shares increased from 5M to 25M via Certificate of Amendment filed Dec 19, 2024.","Shareholders approved exercise of warrants for 837,104 shares issued in Oct 23, 2024 private placement.","Series A and B Preferred Stock certificates withdrawn; no shares outstanding at time.","Proposal I passed with over 64M combined votes for vs 35M against (including preferred stock auto-vote).","Proposal II passed with 301,878 for, 105,960 against, 420,793 broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187507,"accession_number":"0001477932-24-006644","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2024-10-23T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"CELZ raises $1.85M in registered direct offering of shares and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds ~$1.85M; net ~$1.6M after fees and expenses; proceeds for working capital.","Offering of 418,552 shares at $4.42; warrants for up to 837,104 shares at $4.42.","Warrants exercisable after stockholder approval, five-year term; closed Oct 23, 2024.","Roth Capital Partners served as exclusive placement agent; offering under effective S-3."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204003,"accession_number":"0001477932-24-004377","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2024-07-25T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Creative Medical Technology Holds 2024 Annual Meeting; Say-on-Pay Vote Fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Five director nominees elected; Timothy Warbington and others received >300K votes for vs ~147K withhold.","Say-on-pay vote: 217,019 for, 227,926 against, 15,317 abstain, with 371,908 broker non-votes; not approved.","Ratification of Haynie & Company as auditor passed with 684,717 for, 90,973 against, 56,480 abstain.","Proposal to increase authorized shares was withdrawn by management before the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.35,"calibrated_materiality_score":0.15,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220688,"accession_number":"0001477932-24-003116","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2024-05-17T23:59:59+00:00","items":["1.01","3.02","3.03","5.03","5.08","9.01"],"status":"ready","headline":"CEO buys one Series B Preferred share with special voting rights on share increase; annual meeting July 19","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Timothy Warbington purchased one Series B Preferred share for $100; it carries 100M votes on share increase proposal.","Series B Preferred votes proportionally with common stock on proposal to increase authorized common from 5M to 25M shares.","Series B automatically redeemed upon approval of share increase; not convertible into common.","Annual meeting of stockholders set for July 19, 2024; record date June 3, 2024.","Preliminary proxy statement filed with SEC regarding share increase and other proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257811,"accession_number":"0001477932-23-009261","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2023-12-20T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Shareholders elect all five director nominees and approve say-on-pay at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Quorum of 55.9% (776,982 shares) present at December 20, 2023 annual meeting.","All five director nominees elected with 234,462 to 237,729 votes in favor; no dissent above 26,758.","Say-on-pay approved: 169,498 for, 90,645 against, 1,077 abstain, 515,762 broker non-votes.","Ratification of auditor Haynie & Company approved: 751,848 for, 23,485 against, 1,649 abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":292585,"accession_number":"0001477932-23-004849","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2023-06-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Creative Medical regains Nasdaq minimum bid price compliance after 10-day stretch above $1.00","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on June 27, 2023 that it regained compliance with Listing Rule 5550(a)(2).","Closing bid price exceeded $1.00 for 10 consecutive trading days (June 12–26, 2023).","Previously notified of non-compliance on July 8, 2022; now compliant with all listing standards.","CEO states company has sufficient funds to meet operating costs and capex through 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":292584,"accession_number":"0001477932-23-004441","cik":1187953,"company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","form_type":"8-K","filed_at":"2023-06-09T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"Creative Medical Technology announces 1-for-10 reverse stock split effective June 12, 2023 to regain Nasdaq compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split ratio 1-for-10; outstanding shares reduced from ~14.1M to ~1.4M.","Authorized shares cut from 50M to 5M; no change to par value of $0.001.","Effective 9:00 a.m. ET on June 12, 2023 under ticker CELZ; new CUSIP 22529Y408.","Fractional shares rounded up to whole share; no cash paid in lieu.","Action intended to bring stock above $1.00 minimum bid price for Nasdaq listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":8502336.32034632,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}